-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Enfusion, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2019 to Q4 2024.
- Enfusion, Inc. Operating Income (Loss) for the quarter ending 31 Dec 2024 was $1,584,000.000, a 25.8% decline year-over-year.
- Enfusion, Inc. Operating Income (Loss) for the twelve months ending 31 Dec 2024 was $6,155,000.000, a 48.5% decline year-over-year.
- Enfusion, Inc. annual Operating Income (Loss) for 2024 was $6,155,000.000, a 48.5% decline from 2023.
- Enfusion, Inc. annual Operating Income (Loss) for 2023 was $11,948,000.000.
- Enfusion, Inc. annual Operating Income (Loss) for 2022 was -$11,964,000.000, a 95.7% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)